TocopherX

Developer of therapeutic medicines designed to treat reproductive infertility. The company's medicines combine the activity of both the male and female hormones which are used to treat infertility into a single molecule delivered in a tablet which could treat both men and women, enabling infertile couples to achieve their family plans in an effective way with less stress.

TocopherX was acquired by Merck KGaA, Darmstadt, Germany in 2020